Freenome (FRNM)
Blood-based cancer screening built on multiomic, AI-driven detection.
$16.57
vs last close−0.03 (−0.16%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Insiders | 47.98% | 3.91M shares | |
|---|---|---|---|
| 10 holders · as of Sep 4, 2026 | |||
| Strategic holders | 28.84% | 2.35M shares | |
| 1 holder · as of Jul 23, 2026 | |||
| Other | 23.18% | 1.89M shares | |
| remainder | |||
8.16M company shares as of Aug 21, 2026 · holders as of their latest filing
The share count has not been confirmed by a second filing; stakes use it as it stands.
13F
No 13F holders on record.
13D/G · 5% or more, as filed
No 13D/G filer at 5% or more on record.
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.
